Status | Study |
Recruiting |
Study Name: Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study Condition: Nephrosis, Lipoid Date: 2010-08-13 Interventions: Drug: Myfortic plus low-dose steroid |
Recruiting |
Study Name: Nephrotic Syndrome Study Network Condition: Minimal Change Disease (MCD) Membranous Nephropathy Date: 2010-07-29 Interventions: Procedure: Kidney Biopsy Patients scheduled to undergo a clinically indicated kidney biopsy will be requ |
Completed |
Study Name: Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) Condition: Treatment Resistant Nephrotic Syndrome Date: 2010-05-21 Interventions: Drug: ACTHAR gel Patients will be treated with ACTHAR gel starting with 40 units given twice weekly subc |
Completed |
Study Name: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome Condition: Minimal Change Disease Date: 2010-03-10 Interventions: Drug: Tacrolimus tacrolimus 0.05mg/kg bid for 12 weeks corticosteroid 0.3 - 0.5mg/kg qd |
Recruiting |
Study Name: Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease Condition: Minimal Change Disease Date: 2009-09-21 Interventions: Drug: tacrolimus tacrolimus0.0 |
Completed |
Study Name: Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) Condition: Nephrotic Syndrome Date: 2009-09-21 Interventions: Drug: Rituximab Rituximab (375 mg/m2) will be given as a single intravenous infusion after reconstitutio |
Completed |
Study Name: Kidney Disease Biomarkers Condition: Kidney Disease Glomerular Disease Idiopathic Nephrotic Syn Date: 2006-07-07 |
Completed |
Study Name: Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis Condition: Collapsing Glomerulopathy Glomerulosclerosis, Focal Segmental Date: 2004-12-01 Interventions: Procedure: Kidney needle biopsy Procedure: |
Completed |
Study Name: Steroid Treatment for Kidney Disease Condition: Nephrosis Focal Lipoid Glomerulosclerosis Date: 2003-07-28 Interventions: Drug: Oral dexamethasone Stage I: Dexamethasone 25 mg/m2, |